Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer (SCCHN)
This study is ongoing, but not recruiting participants.
Study NCT00671437
Information provided by Washington University School of Medicine
First Received on May 1, 2008.
Last Updated on December 20, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
